Morgan Stanley
OM icon

Morgan Stanley’s Outset Medical OM Stock Holding History

Morgan Stanley’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$786K Buy
181,983
+12,540
+7% +$54.9K ﹤0.01% 5337
2026
Q1 		$651K Buy
169,443
+29,724
+21% +$122K ﹤0.01% 5347
2025
Q4 		$518K Sell
139,719
-293,456
-68% -$2.52M ﹤0.01% 5495
2025
Q3 		$6.12M Buy
433,175
+311,805
+257% +$4.86M ﹤0.01% 3988
2025
Q2 		$2.33M Buy
121,370
+56,676
+88% +$885K ﹤0.01% 4602
2025
Q1 		$716K Sell
64,694
-31,057
-32% -$370K ﹤0.01% 5164
2024
Q4 		$1.59M Buy
95,751
+16,800
+21% +$210K ﹤0.01% 4850
2024
Q3 		$802K Sell
78,951
-175,400
-69% -$5.22M ﹤0.01% 5166
2024
Q2 		$14.7M Sell
254,351
-13,107
-5% -$642K ﹤0.01% 2992
2024
Q1 		$8.91M Buy
267,458
+9,587
+4% +$485K ﹤0.01% 3440
2023
Q4 		$20.9M Buy
257,871
+151,256
+142% +$12.3M ﹤0.01% 2644
2023
Q3 		$17.4M Buy
106,615
+70,073
+192% +$16.5M ﹤0.01% 2615
2023
Q2 		$12M Buy
36,542
+3,629
+11% +$1.11M ﹤0.01% 2998
2023
Q1 		$9.08M Sell
32,913
-9,098
-22% -$3.34M ﹤0.01% 3230
2022
Q4 		$16.3M Buy
42,011
+13,233
+46% +$3.73M ﹤0.01% 2553
2022
Q3 		$6.88M Buy
28,778
+1,199
+4% +$321K ﹤0.01% 3366
2022
Q2 		$6.15M Buy
27,579
+9,026
+49% +$3.88M ﹤0.01% 3571
2022
Q1 		$12.6M Sell
18,553
-13,917
-43% -$8.37M ﹤0.01% 2632
2021
Q4 		$22.4M Buy
32,470
+3,907
+14% +$2.89M ﹤0.01% 2029
2021
Q3 		$21.2M Buy
28,563
+6,216
+28% +$4.24M ﹤0.01% 2031
2021
Q2 		$16.8M Buy
22,347
+4,788
+27% +$3.66M ﹤0.01% 2354
2021
Q1 		$14.3M Buy
17,559
+1,290
+8% +$995K ﹤0.01% 2275
2020
Q4 		$13.9M Sell
16,269
-180
-1% -$139K ﹤0.01% 2176
2020
Q3 		$12.3M Buy
+16,449
New +$13.5M ﹤0.01% 1859

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Morgan Stanley's OM Position: Q2 2026 in Review

Morgan Stanley increased its Outset Medical (OM) stake by 7.4% in Q2 2026, buying an estimated $54.9K and bringing the position to 181,983 shares worth $786K. The position accounts for ﹤0.01% of the portfolio, ranked #5337.

Morgan Stanley first reported a position in OM in Q3 2020 and has held it in 24 quarters since. The position peaked at $22.4M in Q4 2021. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • Morgan Stanley held 181,983 shares of Outset Medical worth $786K as of Q2 2026.
  • Morgan Stanley bought 12,540 Outset Medical shares in Q2 2026, an estimated $54.9K.
  • Outset Medical made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5337 holding.
  • Morgan Stanley first reported a position in Outset Medical in Q3 2020 and has held it in 24 quarters since.
  • Morgan Stanley's Outset Medical position peaked at $22.4M in Q4 2021.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.